Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.108 (
TAT
)
2,389
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Membrane trafficking processes regulate G protein-coupled receptor (GPCR) activity. Although class A GPCRs are capable of activating G proteins in a monomeric form, they can also potentially assemble into functional GPCR heteromers. Here, we showed that the class A serotonin 5-HT
2A
receptors (5-HT
2A
Rs) affected the localization and trafficking of class C
metabotropic glutamate receptor 2
(
mGluR2
) through a mechanism that required their assembly as heteromers in mammalian cells. In the absence of agonists, 5-HT
2A
R was primarily localized within intracellular compartments, and coexpression of 5-HT
2A
R with
mGluR2
increased the intracellular distribution of the otherwise plasma membrane-localized
mGluR2
. Agonists for either 5-HT
2A
R or
mGluR2
differentially affected trafficking through Rab5-positive endosomes in cells expressing each component of the 5-HT
2A
R-
mGluR2
heterocomplex alone, or together. In addition, overnight pharmacological 5-HT
2A
R blockade with clozapine, but not with M100907, decreased
mGluR2
density through a mechanism that involved heteromerization between 5-HT
2A
R and
mGluR2
. Using
TAT
-tagged peptides and chimeric constructs that are unable to form the interclass 5-HT
2A
R-
mGluR2
complex, we demonstrated that heteromerization was necessary for the 5-HT
2A
R-dependent effects on
mGluR2
subcellular distribution. The expression of 5-HT
2A
R also augmented intracellular localization of
mGluR2
in mouse frontal cortex pyramidal neurons. Together, our data suggest that GPCR heteromerization may itself represent a mechanism of receptor trafficking and sorting.
...
PMID:Interclass GPCR heteromerization affects localization and trafficking. 3308 87